Clinical trial starts for new obesity drugs U.S. 2008-2017

Published by
Matej Mikulic,
Apr 18, 2019
This statistic depicts the number of clinical trial starts for novel obesity drugs in the U.S. from 2008 to 2017. According to the data, the number of yearly clinical trials has decreased from 11 in 2008 to 0 in 2013. In 2017, there were again five clinical trial starts obesity drug intervention trials.

Number of clinical trial starts for obesity novel drugs in the U.S. from 2008 to 2017

© Statista 2024
Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

2019

Region

United States

Survey time period

2008 to 2017

Citation formats
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts

Statistics on " Diabetes in the U.S. "

The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics
The most important statistics

Other statistics that may interest you Diabetes in the U.S.

Overview

4

Prediabetes

6

Prevalence and incidence of diabetes

8

Prepregnancy diabetes

5

Diabetic retinopathy

4

Deaths

4

Risk factor: Obesity

5

Further related statistics

10

Further Content: You might find this interesting as well

Statistics

Topics

Biotech drugsGlobal pharmaceutical industryCancer in the U.S.AmgenCoronavirus (COVID-19) vaccines and treatments
Access all statistics starting from $2,388 USD yearly *

* For commercial use only

Basic Account

For single users
$0 USD
Always free
Access limited to Free Statistics. Premium Statistics are not included.
  • Free Statistics
Based on your interests

Starter Account

For single users
$199 USD
per month, billed annually 1
Buy now
  • Free Statistics
  • Premium Statistics

    • The statistic on this page is a Premium Statistic and is included in this account.

Professional Account

For teams of up to 5 people
$959 USD
per month, billed annually 1
Buy now
  • Free + Premium Statistics
  • Reports
  • Market Insights

1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.

Compare accounts
Learn more about how Statista can support your business.